BiVacor announced today that it received FDA breakthrough device designation for its Total Artificial Heart (TAH) system.

Clinical-stage company earns key regulatory milestone as it advances a first-of-its-kind heart replacement system toward wider use. HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--BiVACOR, a clinical ...

On July 26 of last year, we reported that the first maglev artificial heart made by the BiVACOR company had been implanted inside the body of a patient at the Texas Heart Institute. The goal of ...

“The entire BiVACOR team is deeply grateful to the patient and his family for placing their trust in our Total Artificial Heart,” he said in the statement. “Their bravery will pave the way ...

He became the first recipient in Australia of the BiVACOR total artificial heart, a device designed to completely replace a ...

Dr. Robert Jarvik, who was a key designer of the first permanent artificial heart implanted in a human, died on Monday in his ...

BiVACOR, a clinical-stage medical device company developing the world’s first titanium Total Artificial Heart (TAH), today announced that its device has received Breakthrough Device Designation ...

An Australian man lived for 100 days with an artificial titanium heart while he awaited a donor transplant, the longest ...

He worked with a team at the University of Utah to create a mechanical heart. It was later used in patients awaiting an organ ...